Drugs Made In America Acquisition Corp.
DMAAUNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for DMAAU. That does not mean none is planned.
Get an email about DMAAU's next catalysts
Track Drugs Made In America Acquisition (DMAAU) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
FS-1 | Phase 3 | Tuberculosis, MDR | - | - |
Frequently asked questions
What is in Drugs Made In America Acquisition Corp.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Drugs Made In America Acquisition Corp.'s (DMAAU) pipeline across Phase 3. Its lead program is FS-1 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Drugs Made In America Acquisition Corp.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Drugs Made In America Acquisition Corp. (DMAAU) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track DMAAU biotech catalysts?→
Add DMAAU to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Drugs Made In America Acquisition Corp.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.